SpyGlass Ophthalmics, an ophthalmic therapeutics company, has secured $27.5 million in Series B financing. The investors were Vensana Capital and New Enterprise Associates.
Source: Press Release
SpyGlass Ophthalmics snags $27.5m Series B
SpyGlass Ophthalmics, an ophthalmic therapeutics company, has secured $27.5 million in Series B financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: